Lawmakers Push 1498 Statute To Cut GLP-1 Drug Prices, Generic Lobby Seeks Broader Reform

By Maaisha Osman / September 24, 2024 at 2:36 PM

A group of House and Senate Democrats are backing drug pricing advocates’ call for the administration to lower the cost of GLP-1 drugs by invoking a rarely used patent-breaking process, coming as the generic drug lobby pushes for broader reforms to the patent system.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.